Armata Pharmaceuticals Inc (ARMP)
2.55
-0.05
(-1.92%)
USD |
NYAM |
Apr 30, 16:00
2.55
0.00 (0.00%)
After-Hours: 17:31
Armata Pharmaceuticals Cash and Short Term Investments (Quarterly): 13.52M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 13.52M |
September 30, 2023 | 23.96M |
June 30, 2023 | 12.46M |
March 31, 2023 | 25.11M |
December 31, 2022 | 14.85M |
September 30, 2022 | 25.38M |
June 30, 2022 | 36.98M |
March 31, 2022 | 46.41M |
December 31, 2021 | 10.29M |
September 30, 2021 | 12.08M |
June 30, 2021 | 17.54M |
March 31, 2021 | 22.46M |
December 31, 2020 | 9.649M |
September 30, 2020 | 15.88M |
June 30, 2020 | 19.79M |
March 31, 2020 | 24.21M |
December 31, 2019 | 6.033M |
September 30, 2019 | 8.69M |
June 30, 2019 | 13.19M |
March 31, 2019 | 5.535M |
December 31, 2018 | 8.157M |
September 30, 2018 | 4.499M |
June 30, 2018 | 5.798M |
March 31, 2018 | 8.206M |
December 31, 2017 | 5.132M |
Date | Value |
---|---|
September 30, 2017 | 7.725M |
June 30, 2017 | 8.962M |
March 31, 2017 | 2.202M |
December 31, 2016 | 5.711M |
September 30, 2016 | 3.967M |
June 30, 2016 | 7.144M |
March 31, 2016 | 6.173M |
December 31, 2015 | 9.37M |
September 30, 2015 | 11.74M |
June 30, 2015 | 14.35M |
March 31, 2015 | 16.62M |
December 31, 2014 | 6.581M |
September 30, 2014 | 9.786M |
June 30, 2014 | 12.55M |
March 31, 2014 | 16.44M |
December 31, 2013 | 20.36M |
September 30, 2009 | 3.974M |
June 30, 2009 | 2.469M |
March 31, 2009 | 3.916M |
December 31, 2008 | 5.216M |
September 30, 2008 | 9.183M |
June 30, 2008 | 12.70M |
March 31, 2008 | 12.86M |
December 31, 2007 | 16.44M |
September 30, 2007 | 20.53M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
6.033M
Minimum
Dec 2019
46.41M
Maximum
Mar 2022
18.87M
Average
15.88M
Median
Sep 2020
Cash and Short Term Investments (Quarterly) Benchmarks
AIM ImmunoTech Inc | 13.07M |
Perspective Therapeutics Inc | 9.238M |
Protalix BioTherapeutics Inc | 44.56M |
Electromed Inc | 10.43M |
Xtant Medical Holdings Inc | 5.715M |